Dr. Imran Muhammad Abassi, MD

Dr. Abassi practices at Inova Fairfax Hospital - Unit in Falls Church, Virginia.

Dr. Abassi's NPI, 1003875014, was assigned on March 20, 2006. Dr. Abassi holds Virginia license 0101241341.

Dr. Abassi's primary practice is Inova Fairfax Hospital - Unit, at 3300 Gallows Rd, Falls Church, VA 22046 in Falls Church City. The practice phone is (703) 698-3659.

Dr. Abassi's primary practice is Inova Fairfax Hospital - Unit in Falls Church, Virginia. Dr. Abassi is also affiliated with Inova Loudoun Hospital. The medical group on file is Inova Urgent Care Center. Dmand AI also links Dr. Abassi to 3 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abassi practices, 3 sites in all. Vendor and product names are available with a free account.

Geriatric psychiatry is Dr. Abassi's primary specialty in the NPI Registry, under taxonomy code 2084P0805X. Dmand AI has Dr. Abassi's licenses on file in 3 states: Virginia, Ohio and West Virginia.

CMS data shows 554 Medicare services from Dr. Abassi across 12 procedure codes in 2024, for 244 Medicare patients. Medicare paid $43,059 for them.

CMS counts 244 Medicare patients who saw Dr. Abassi in 2024. The largest group is 85 and over, with 100 patients. 75% of them have anxiety, and 75% have depression. 38% are also on Medicaid. Their average risk score is 1.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Abassi's median patient age at 34, with 58% women.

In 2024, Dr. Abassi wrote 1,020 Medicare Part D claims for 131 patients. 96% of them were for generic drugs. CMS names the drug for 920 of them, across 22 drugs with 11 or more claims each, at $23,636 in total drug cost. In 2023, CMS named 581 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Abassi for performance year 2024, reported through an alternative payment model (APM). Dr. Abassi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Abassi as offering telehealth.

CMS Open Payments shows 50 general payments to Dr. Abassi from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $206.